Calithera Biosciences, Inc. (CALA)
OTCMKTS · Delayed Price · Currency is USD
0.0050
+0.0049 (4,900.00%)
Apr 24, 2025, 4:00 PM EDT

Calithera Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022 FY 2021 FY 2020 FY 2019 FY 2018 2013 - 2017
Period Ending
Apr '25 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 2013 - 2017
Market Capitalization
01650346307153
Upgrade
Market Cap Growth
-68.18%-68.18%-85.61%12.83%100.84%-48.39%
Upgrade
Enterprise Value
-6-3121618211
Upgrade
Last Close Price
0.013.2613.3098.20114.2080.20
Upgrade
PS Ratio
--5.11--6.87
Upgrade
PB Ratio
0.000.781.013.382.161.21
Upgrade
P/TBV Ratio
--5.953.382.161.21
Upgrade
EV/Sales Ratio
-----0.51
Upgrade
Debt / Equity Ratio
0.080.080.060.070.06-
Upgrade
Asset Turnover
--0.10--0.13
Upgrade
Quick Ratio
3.443.444.256.348.049.28
Upgrade
Current Ratio
3.603.604.396.458.149.43
Upgrade
Return on Equity (ROE)
-114.14%-114.14%-151.98%-73.64%-66.78%-39.44%
Upgrade
Return on Assets (ROA)
-56.29%-56.29%-75.81%-38.81%-37.28%-21.36%
Upgrade
Return on Capital (ROIC)
-70.90%-70.90%-89.50%-43.98%-41.87%-25.85%
Upgrade
Earnings Yield
-87390.20%-249.99%-230.91%-26.02%-29.27%-35.73%
Upgrade
FCF Yield
-179546.01%-275.78%-133.32%-24.35%-25.65%-42.55%
Upgrade
Buyback Yield / Dilution
-35.17%-35.17%-7.32%-45.46%-29.25%-11.09%
Upgrade
Updated Mar 31, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.